Cardiac effects of growth hormone treatment in pediatric populations

Steven E. Lipshultz, Janine E Sanchez, Adriana Carrillo, Shannon Preble, Rebecca E. Scully

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

While the full extent of the role that growth hormone (GH) and its effector Insulin-like growth factor 1 (IGF-1) play in the development and maintenance of cardiovascular morphology and function is debated, several conditions associated with altered GH activity have characteristic cardiovascular impairments.[1-3] The effects of GH therapy on cardiac function have been studied in the pediatric population, primarily in the setting of GH deficiency. For individuals whose circulating levels of GH are low, GH replacement therapy appears to improve cardiovascular health. GH therapy has also been shown to improve lean body mass and decrease percent body fat, which may further improve overall cardiovascular health. However, GH excess may lead to cardiac hypertrophy, as seen in acromegaly. GH therapy may also lead to reduced insulin sensitivity, a pre-diabetic state, in some individuals, particularly women with Turner syndrome. Thus, the systemic effects of GH therapy, specifically its effect on the cardiovascular system, vary by underlying condition.

Original languageEnglish (US)
Title of host publicationAdvances in Medicine and Biology
PublisherNova Science Publishers, Inc.
Pages323-336
Number of pages14
Volume1
ISBN (Electronic)9781613241639
ISBN (Print)9781608768639
StatePublished - Jan 1 2010

Fingerprint

Growth Hormone
Pediatrics
Population
Therapeutics
Turner Syndrome
Acromegaly
Hormone Replacement Therapy
Health
Cardiomegaly
Somatomedins
Cardiovascular System
Insulin Resistance
Adipose Tissue
Maintenance

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)

Cite this

Lipshultz, S. E., Sanchez, J. E., Carrillo, A., Preble, S., & Scully, R. E. (2010). Cardiac effects of growth hormone treatment in pediatric populations. In Advances in Medicine and Biology (Vol. 1, pp. 323-336). Nova Science Publishers, Inc..

Cardiac effects of growth hormone treatment in pediatric populations. / Lipshultz, Steven E.; Sanchez, Janine E; Carrillo, Adriana; Preble, Shannon; Scully, Rebecca E.

Advances in Medicine and Biology. Vol. 1 Nova Science Publishers, Inc., 2010. p. 323-336.

Research output: Chapter in Book/Report/Conference proceedingChapter

Lipshultz, SE, Sanchez, JE, Carrillo, A, Preble, S & Scully, RE 2010, Cardiac effects of growth hormone treatment in pediatric populations. in Advances in Medicine and Biology. vol. 1, Nova Science Publishers, Inc., pp. 323-336.
Lipshultz SE, Sanchez JE, Carrillo A, Preble S, Scully RE. Cardiac effects of growth hormone treatment in pediatric populations. In Advances in Medicine and Biology. Vol. 1. Nova Science Publishers, Inc. 2010. p. 323-336
Lipshultz, Steven E. ; Sanchez, Janine E ; Carrillo, Adriana ; Preble, Shannon ; Scully, Rebecca E. / Cardiac effects of growth hormone treatment in pediatric populations. Advances in Medicine and Biology. Vol. 1 Nova Science Publishers, Inc., 2010. pp. 323-336
@inbook{8daac7a9cb494055a1beacbc143df1d8,
title = "Cardiac effects of growth hormone treatment in pediatric populations",
abstract = "While the full extent of the role that growth hormone (GH) and its effector Insulin-like growth factor 1 (IGF-1) play in the development and maintenance of cardiovascular morphology and function is debated, several conditions associated with altered GH activity have characteristic cardiovascular impairments.[1-3] The effects of GH therapy on cardiac function have been studied in the pediatric population, primarily in the setting of GH deficiency. For individuals whose circulating levels of GH are low, GH replacement therapy appears to improve cardiovascular health. GH therapy has also been shown to improve lean body mass and decrease percent body fat, which may further improve overall cardiovascular health. However, GH excess may lead to cardiac hypertrophy, as seen in acromegaly. GH therapy may also lead to reduced insulin sensitivity, a pre-diabetic state, in some individuals, particularly women with Turner syndrome. Thus, the systemic effects of GH therapy, specifically its effect on the cardiovascular system, vary by underlying condition.",
author = "Lipshultz, {Steven E.} and Sanchez, {Janine E} and Adriana Carrillo and Shannon Preble and Scully, {Rebecca E.}",
year = "2010",
month = "1",
day = "1",
language = "English (US)",
isbn = "9781608768639",
volume = "1",
pages = "323--336",
booktitle = "Advances in Medicine and Biology",
publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - Cardiac effects of growth hormone treatment in pediatric populations

AU - Lipshultz, Steven E.

AU - Sanchez, Janine E

AU - Carrillo, Adriana

AU - Preble, Shannon

AU - Scully, Rebecca E.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - While the full extent of the role that growth hormone (GH) and its effector Insulin-like growth factor 1 (IGF-1) play in the development and maintenance of cardiovascular morphology and function is debated, several conditions associated with altered GH activity have characteristic cardiovascular impairments.[1-3] The effects of GH therapy on cardiac function have been studied in the pediatric population, primarily in the setting of GH deficiency. For individuals whose circulating levels of GH are low, GH replacement therapy appears to improve cardiovascular health. GH therapy has also been shown to improve lean body mass and decrease percent body fat, which may further improve overall cardiovascular health. However, GH excess may lead to cardiac hypertrophy, as seen in acromegaly. GH therapy may also lead to reduced insulin sensitivity, a pre-diabetic state, in some individuals, particularly women with Turner syndrome. Thus, the systemic effects of GH therapy, specifically its effect on the cardiovascular system, vary by underlying condition.

AB - While the full extent of the role that growth hormone (GH) and its effector Insulin-like growth factor 1 (IGF-1) play in the development and maintenance of cardiovascular morphology and function is debated, several conditions associated with altered GH activity have characteristic cardiovascular impairments.[1-3] The effects of GH therapy on cardiac function have been studied in the pediatric population, primarily in the setting of GH deficiency. For individuals whose circulating levels of GH are low, GH replacement therapy appears to improve cardiovascular health. GH therapy has also been shown to improve lean body mass and decrease percent body fat, which may further improve overall cardiovascular health. However, GH excess may lead to cardiac hypertrophy, as seen in acromegaly. GH therapy may also lead to reduced insulin sensitivity, a pre-diabetic state, in some individuals, particularly women with Turner syndrome. Thus, the systemic effects of GH therapy, specifically its effect on the cardiovascular system, vary by underlying condition.

UR - http://www.scopus.com/inward/record.url?scp=85060156766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060156766&partnerID=8YFLogxK

M3 - Chapter

SN - 9781608768639

VL - 1

SP - 323

EP - 336

BT - Advances in Medicine and Biology

PB - Nova Science Publishers, Inc.

ER -